Osteosarcoma treatment–where do we stand? A state of the art review

A Luetke, PA Meyers, I Lewis, H Juergens - Cancer treatment reviews, 2014 - Elsevier
Long-term outcome for patients with high-grade osteosarcoma has improved with the
addition of systemic chemotherapy, but subsequent progress has been less marked …

[HTML][HTML] Progress in the chemotherapeutic treatment of osteosarcoma

Y Zhang, J Yang, N Zhao, C Wang… - Oncology …, 2018 - spandidos-publications.com
Osteosarcoma (OS) is the most common type of primary bone tumor in children and
adolescents and has been associated with a high degree of malignancy, early metastasis …

Metastatic osteosarcoma: a challenging multidisciplinary treatment

C Meazza, P Scanagatta - Expert review of anticancer therapy, 2016 - Taylor & Francis
Osteosarcoma is the most common malignant bone tumor, currently treated with pre-and
postoperative chemotherapy in association with the surgical removal of the tumor. About 15 …

Bone microenvironment signals in osteosarcoma development

A Alfranca, L Martinez-Cruzado, J Tornin… - Cellular and Molecular …, 2015 - Springer
The bone is a complex connective tissue composed of many different cell types such as
osteoblasts, osteoclasts, chondrocytes, mesenchymal stem/progenitor cells, hematopoietic …

Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine …

NJ Mason, JS Gnanandarajah, JB Engiles, F Gray… - Clinical Cancer …, 2016 - AACR
Abstract Purpose: Recombinant Listeria vaccines induce tumor-specific T-cell responses
that eliminate established tumors and prevent metastatic disease in murine cancer models …

[HTML][HTML] Molecular mechanisms of chemoresistance in osteosarcoma

H He, J Ni, JUN Huang - Oncology letters, 2014 - spandidos-publications.com
Due to the emergence of adjuvant and neoadjuvant chemotherapy, the survival rate has
been greatly improved in osteosarcoma (OS) patients with localized disease. However, this …

Highly‐expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β‐catenin and mTOR/HIF1α/VEGF …

Y Zhang, H Cheng, W Li, H Wu… - International journal of …, 2019 - Wiley Online Library
The P2X7 receptor, an ATP‐gated ion channel, is critical for cancer cell growth,
invasiveness, and angiogenesis. Previous studies indicate that P2X7 regulates osteoblast …

MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration

Z Duan, E Choy, D Harmon, X Liu, M Susa… - Molecular cancer …, 2011 - AACR
Abstract microRNAs (miRNA, miR) play an important role in cancer cell growth and
migration; however, the potential roles of miRNAs in osteosarcoma remain largely …

A deep learning study on osteosarcoma detection from histological images

DM Anisuzzaman, H Barzekar, L Tong, J Luo… - … Signal Processing and …, 2021 - Elsevier
Abstract In the US 5–10% of new pediatric cases of cancer are primary bone tumors. The
most common type of primary malignant bone tumor is osteosarcoma. The intention of the …

Osteosarcoma

R Gorlick, C Khanna - Journal of bone and mineral research, 2010 - academic.oup.com
It has been difficult to identify the molecular features central to the pathogenesis of
osteosarcoma owing to a lack of understanding of the cell or origin, the absence of …